Denali Therapeutics Inc.

NASDAQ:DNLI

31.05 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 00-305.0431.267294.12335.14110.2833.55952.4842.14112.5145.28522.9397.923316.8159.3935.8473.6044.67213.6044.1974.205125.6761.1951.6480.641145.1490000000
Cost of Revenue 1.9422.1622.1772.2171.3579.173.2281.2761.2321.2961.31171.55965.71160.20754.74353.70453.15251.01651.55152.54451.88437.40339.90930.32152.13420.81918.47118.51519.00418.470000
Gross Profit -1.942-2.162-307.22-0.95292.76625.9717.0552.28351.24840.84511.203-66.274-42.772-52.284262.072-44.311-47.305-47.412-46.879-38.94-47.687-33.19885.767-29.126-50.486-20.178126.678-18.515-19.004-18.470000
Gross Profit Ratio 001.007-0.750.9950.7390.6860.6410.9770.9690.895-12.54-1.865-6.5990.827-4.717-8.09-13.155-10.034-2.862-11.362-7.8950.682-24.373-30.635-31.4790.8730000000
Reseach & Development Expenses 91.399107.016107.80389.73797.52128.81692.11187.78692.73786.09867.87671.55965.71160.20754.74353.70453.15251.01651.55152.54451.88437.40339.90930.32152.13420.81918.47118.51519.00418.4716.7327.81915.57715.577
General & Administrative Expenses 25.19425.23624.76925.32526.1227.1423.51623.25921.15922.54121.75919.31919.04518.93617.99415.80513.97212.55510.87911.21515.0769.3111.0458.8386.8965.575.0693.7733.5643.2743.0463.1132.7862.786
Selling & Marketing Expenses -1.942-2.162-2.1770000000000000000000000000000000
SG&A 23.25223.07422.59225.32526.1227.1423.51623.25921.15922.54121.75919.31919.04518.93617.99415.80513.97212.55510.87911.21515.0769.3111.0458.8386.8965.575.0693.7733.5643.2743.0463.1132.7862.786
Other Expenses 0000000000000000000000000000000000
Operating Expenses 114.651130.09130.395115.062123.64155.956115.627111.045113.896108.63989.63590.87884.75679.14372.73769.50967.12463.57162.4363.75966.9646.71350.95439.15959.0326.38923.5422.28822.56821.74419.77630.93218.36218.362
Operating Income -116.593-132.252-132.572-113.795170.483-120.815-105.344-107.486-61.416-66.498-77.121-85.593-61.817-71.22244.078-60.116-61.277-59.967-57.758-50.155-62.763-42.50874.722-37.964-57.382-25.748-23.54-22.288-22.568-21.744-19.866-25.632-18.363-18.363
Operating Income Ratio 000.435-89.8150.58-3.438-10.244-30.201-1.17-1.578-6.163-16.195-2.695-8.9890.77-6.4-10.48-16.639-12.363-3.687-14.954-10.1090.595-31.769-34.819-40.168-0.1620000000
Total Other Income Expenses Net 17.56730.4513.12914.44212.911.0346.664.1872.6491.2781.2851.0051.1261.1791.631.9442.5983.0693.8083.7824.1133.5162.8112.5932.6582.070.6530.4440.4340.4240.512-4.9790.0190.019
Income Before Tax -99.026-101.802-119.443-99.353183.383-109.781-98.684-103.299-58.767-65.22-75.836-84.588-60.691-70.041245.708-58.172-58.679-56.898-53.95-46.373-58.65-38.99277.533-35.371-54.724-23.678-22.887-21.844-22.134-21.32-19.354-30.611-18.344-18.344
Income Before Tax Ratio 000.392-78.4160.623-3.124-9.597-29.025-1.12-1.548-6.06-16.005-2.646-8.840.776-6.193-10.036-15.787-11.548-3.409-13.974-9.2730.617-29.599-33.206-36.939-0.1580000000
Income Tax Expense 02.1190.032.257-2.285-10.047-0.0062.1140.027-1.278-0.5750.7820.728-2.1080.8230.0560.079-0.1350.075-0.113-0.3130-2.379000-0.8070000.09000
Net Income -99.026-101.802-119.473-99.353183.383-109.781-98.678-103.299-58.794-63.942-75.261-84.588-60.691-70.041244.885-58.228-58.758-56.763-54.025-46.26-58.337-38.99277.533-35.371-54.724-23.678-22.887-21.844-22.134-21.32-19.354-30.611-18.344-18.344
Net Income Ratio 000.392-78.4160.623-3.124-9.596-29.025-1.12-1.517-6.014-16.005-2.646-8.840.773-6.199-10.049-15.75-11.564-3.4-13.9-9.2730.617-29.599-33.206-36.939-0.1580000000
EPS -0.59-0.68-0.86-0.721.34-0.8-0.74-0.84-0.48-0.52-0.62-0.69-0.5-0.582.04-0.54-0.56-0.55-0.57-0.48-0.61-0.410.82-0.38-0.59-0.26-0.74-0.27-0.32-2.36-2.15-4.51-3.37-3.37
EPS Diluted -0.59-0.68-0.86-0.721.3-0.8-0.74-0.84-0.48-0.52-0.62-0.69-0.49-0.581.91-0.54-0.56-0.55-0.56-0.48-0.61-0.410.79-0.38-0.59-0.26-0.74-0.27-0.32-2.36-2.15-4.51-3.37-3.37
EBITDA -114.651-130.09-130.395-111.578170.483-120.815-101.253-105.345-59.344-64.419-77.121-83.406-59.613-71.22244.078-57.96-59.132-57.858-57.758-48.265-61.12-40.10574.722-35.637-55.527-24.894-23.54-21.51-21.802-21.013-19.09-25.231-18.172-18.172
EBITDA Ratio 000.427-88.0650.58-3.438-9.847-29.6-1.131-1.529-6.163-15.782-2.599-8.9890.77-6.171-10.113-16.054-12.363-3.548-14.563-9.5370.595-29.822-33.694-38.836-0.1620000000